• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高通量药代动力学方法:小鼠中的多剂量给药与微量连续采血及液相色谱/串联质谱分析相结合。

High-throughput pharmacokinetic method: cassette dosing in mice associated with minuscule serial bleedings and LC/MS/MS analysis.

作者信息

Watanabe Takaho, Schulz Daniela, Morisseau Christophe, Hammock Bruce D

机构信息

Department of Entomology and UCD Cancer Center, University of California, One Shields Avenue, Davis, CA 95616, USA.

出版信息

Anal Chim Acta. 2006 Feb 10;559(1):37-44. doi: 10.1016/j.aca.2005.11.049.

DOI:10.1016/j.aca.2005.11.049
PMID:16636700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1447531/
Abstract

A method for pharmacokinetic studies using cassette dosing associated with serial bleeding in mice is described. PK profiles of four soluble epoxide hydrolase inhibitors were determined following oral, subcutaneous or intraperitoneal administration individually or in cassette dosing. Parent analyses were performed on only 5 microL of whole blood from serial bleeds (up to 10 per animal), by LC/MS/MS. An accuracy (88-100%) and precision (<10% RSD) were observed, leading to reliable datum points for PK calculation. PK profiles, T(max), C(max) and half-life values after cassette dosing were similar to the individual PK results. This method dramatically increases speed of data collection while dramatically reducing cost and animal usage. The results presented here clearly indicate that this proposed method could be applicable to high-throughput PK studies.

摘要

描述了一种使用盒式给药并结合小鼠连续采血进行药代动力学研究的方法。分别或采用盒式给药方式经口、皮下或腹腔注射后,测定了四种可溶性环氧化物水解酶抑制剂的药代动力学特征。通过液相色谱/串联质谱法,仅对连续采血(每只动物最多10次)获得的5微升全血进行母体分析。观察到准确度(88 - 100%)和精密度(相对标准偏差<10%),从而得到用于药代动力学计算的可靠数据点。盒式给药后的药代动力学特征、达峰时间(T(max))、峰浓度(C(max))和半衰期值与单独给药的药代动力学结果相似。该方法显著提高了数据收集速度,同时大幅降低了成本和动物使用量。此处给出的结果清楚地表明,所提出的这种方法可应用于高通量药代动力学研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/1447531/3ebbbb0b1c09/nihms-9484-0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/1447531/19d83be6888f/nihms-9484-0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/1447531/aeff72bea9e9/nihms-9484-0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/1447531/fe242815aa4c/nihms-9484-0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/1447531/3ebbbb0b1c09/nihms-9484-0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/1447531/19d83be6888f/nihms-9484-0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/1447531/aeff72bea9e9/nihms-9484-0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/1447531/fe242815aa4c/nihms-9484-0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/267a/1447531/3ebbbb0b1c09/nihms-9484-0004.jpg

相似文献

1
High-throughput pharmacokinetic method: cassette dosing in mice associated with minuscule serial bleedings and LC/MS/MS analysis.高通量药代动力学方法:小鼠中的多剂量给药与微量连续采血及液相色谱/串联质谱分析相结合。
Anal Chim Acta. 2006 Feb 10;559(1):37-44. doi: 10.1016/j.aca.2005.11.049.
2
Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice.评估盒式给药法在小鼠中评估格尔德霉素类似物药代动力学的应用。
Cancer Chemother Pharmacol. 2004 Dec;54(6):475-86. doi: 10.1007/s00280-004-0853-7. Epub 2004 Jul 29.
3
Rapid and simultaneous quantification of a mixture of biopharmaceuticals by a liquid chromatography/quadrupole time-of-flight mass spectrometric method in rat plasma following cassette-dosing.在大鼠血浆中采用盒式给药后,通过液相色谱/四极杆飞行时间质谱法快速同时定量生物药物混合物。
Rapid Commun Mass Spectrom. 2018 Jun 15;32(11):889-896. doi: 10.1002/rcm.8123.
4
Cassette dosing for pharmacokinetic screening in drug discovery: comparison of clearance, volume of distribution, half-life, mean residence time, and oral bioavailability obtained by cassette and discrete dosing in rats.盒式给药用于药物发现中的药代动力学筛选:比较通过盒式和离散给药在大鼠中获得的清除率、分布容积、半衰期、平均驻留时间和口服生物利用度。
J Pharm Sci. 2011 Sep;100(9):3862-74. doi: 10.1002/jps.22525. Epub 2011 Mar 1.
5
Discovery pharmacokinetic studies in mice using serial microsampling, dried blood spots and microbore LC-MS/MS.使用连续微量采样、干血斑和微径液相色谱-串联质谱法在小鼠中开展的发现性药代动力学研究。
Bioanalysis. 2012 May;4(9):1077-95. doi: 10.4155/bio.12.85.
6
Combination of cassette-dosing and microsampling for reduced animal usage for antibody pharmacokinetics in cynomolgus monkeys, wild-type mice, and human FcRn transgenic mice.组合使用盒式给药和微采样以减少用于食蟹猴、野生型小鼠和人 FcRn 转基因小鼠的抗体药代动力学研究中的动物使用量。
Pharm Res. 2021 Apr;38(4):583-592. doi: 10.1007/s11095-021-03028-6. Epub 2021 Mar 29.
7
Generation of High-Quality Pharmacokinetic Data From Parallel Tail Vein Dosing And Bleeding in Non-cannulated Rats.从非插管大鼠的平行尾静脉给药和采血中生成高质量的药代动力学数据。
J Pharm Sci. 2021 Oct;110(10):3491-3499. doi: 10.1016/j.xphs.2021.06.020. Epub 2021 Jun 12.
8
Evaluation and Optimization of Blood Micro-Sampling Methods: Serial Sampling in a Cross-Over Design from an Individual Mouse.个体小鼠交叉设计中连续采血法的评估和优化。
J Pharm Pharm Sci. 2016 Oct-Dec;19(4):496-510. doi: 10.18433/J3NK60.
9
Mass spectrometry imaging of cassette-dosed drugs for higher throughput pharmacokinetic and biodistribution analysis.用于高通量药代动力学和生物分布分析的盒式给药药物的质谱成像
Anal Chem. 2014 Aug 19;86(16):8473-80. doi: 10.1021/ac502217r. Epub 2014 Aug 8.
10
High-throughput analysis of standardized pharmacokinetic studies in the rat using sample pooling and UPLC-MS/MS.采用样品混合和 UPLC-MS/MS 对大鼠进行高通量分析标准化药代动力学研究。
J Pharm Biomed Anal. 2011 Jul 15;55(5):1120-6. doi: 10.1016/j.jpba.2011.03.042. Epub 2011 Apr 6.

引用本文的文献

1
Structure-Activity Relationship Studies of Antimalarial Proteasome Inhibitors─Part II.抗疟蛋白酶体抑制剂的构效关系研究-第二部分。
J Med Chem. 2023 Jan 26;66(2):1484-1508. doi: 10.1021/acs.jmedchem.2c01651. Epub 2023 Jan 11.
2
Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative.运动至可溶环氧化物水解酶抑制剂 EC5026 的临床应用作为治疗神经性疼痛的镇痛药,也可作为非成瘾性阿片类药物替代物。
J Med Chem. 2021 Feb 25;64(4):1856-1872. doi: 10.1021/acs.jmedchem.0c01886. Epub 2021 Feb 7.
3
Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors.

本文引用的文献

1
Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles.环氧水解酶:作用机制、抑制剂设计及生物学作用
Annu Rev Pharmacol Toxicol. 2005;45:311-33. doi: 10.1146/annurev.pharmtox.45.120403.095920.
2
Genetically modified mouse models for pharmacogenomic research.用于药物基因组学研究的转基因小鼠模型。
Nat Rev Genet. 2004 Sep;5(9):657-63. doi: 10.1038/nrg1429.
3
Whatever happened to cassette-dosing pharmacokinetics?盒式给药药代动力学怎么了?
双可溶性环氧化物水解酶/脂肪酸酰胺水解酶抑制剂的设计与效能
ACS Omega. 2018 Oct 31;3(10):14076-14086. doi: 10.1021/acsomega.8b01625. Epub 2018 Oct 25.
4
Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales.十字花目植物中基于尿素的可溶性环氧化物水解酶抑制剂的存在情况。
PLoS One. 2017 May 4;12(5):e0176571. doi: 10.1371/journal.pone.0176571. eCollection 2017.
5
Comprehensive evaluation of formulation factors for ocular penetration of fluoroquinolones in rabbits using cassette dosing technique.采用灌胃给药技术对氟喹诺酮类药物在家兔眼部渗透的制剂因素进行综合评价。
Drug Des Devel Ther. 2016 Feb 22;10:811-23. doi: 10.2147/DDDT.S95870. eCollection 2016.
6
In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors.N-金刚烷基取代的脲基可溶性环氧化物水解酶抑制剂的体外和体内代谢
Biochem Pharmacol. 2015 Dec 15;98(4):718-31. doi: 10.1016/j.bcp.2015.10.013. Epub 2015 Oct 19.
7
The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain.2014年伯纳德·B·布罗迪奖讲座——环氧化物水解酶:从药物代谢到慢性疼痛治疗
Drug Metab Dispos. 2015 May;43(5):788-802. doi: 10.1124/dmd.115.063339. Epub 2015 Mar 11.
8
Synthesis and structure-activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors.哌啶衍生的非尿素可溶性环氧水解酶抑制剂的合成及构效关系。
Bioorg Med Chem Lett. 2013 Jan 15;23(2):417-21. doi: 10.1016/j.bmcl.2012.11.084. Epub 2012 Dec 1.
9
Screening candidate anticancer drugs for brain tumor chemotherapy: pharmacokinetic-driven approach for a series of (E)-N-(substituted aryl)-3-(substituted phenyl)propenamide analogues.筛选候选抗癌药物进行脑肿瘤化疗:一系列(E)-N-(取代芳基)-3-(取代苯基)丙烯酰胺类似物的药代动力学驱动方法。
Invest New Drugs. 2012 Dec;30(6):2263-73. doi: 10.1007/s10637-012-9806-x. Epub 2012 Mar 1.
10
Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.设计、合成及可溶性环氧化物水解酶非尿素抑制剂的评价。
Bioorg Med Chem Lett. 2012 Jan 1;22(1):601-5. doi: 10.1016/j.bmcl.2011.10.074. Epub 2011 Oct 28.
Drug Discov Today. 2004 Aug 1;9(15):652-8. doi: 10.1016/S1359-6446(04)03137-X.
4
Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.作为具有更高水溶性的可溶性环氧化物水解酶强效抑制剂的1,3-二取代脲的设计、合成及生物活性
J Med Chem. 2004 Apr 8;47(8):2110-22. doi: 10.1021/jm030514j.
5
High-performance liquid chromatographic mass spectrometric method for the determination of ursodeoxycholic acid and its glycine and taurine conjugates in human plasma.高效液相色谱-质谱法测定人血浆中熊去氧胆酸及其甘氨酸和牛磺酸共轭物
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Dec 25;798(2):295-302. doi: 10.1016/j.jchromb.2003.09.054.
6
Determination of ketotifen and its conjugated metabolite in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study.液相色谱/串联质谱法测定人血浆中的酮替芬及其共轭代谢物:在药代动力学研究中的应用
Rapid Commun Mass Spectrom. 2003;17(22):2459-63. doi: 10.1002/rcm.1189.
7
Chemical substructures in drug discovery.药物发现中的化学亚结构
Drug Discov Today. 2003 Jul 1;8(13):594-602. doi: 10.1016/s1359-6446(03)02740-5.
8
In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea.哺乳动物可溶性环氧化物水解酶抑制剂1-环己基-3-十二烷基脲的体外代谢
Drug Metab Dispos. 2003 Jul;31(7):846-53. doi: 10.1124/dmd.31.7.846.
9
Hit and lead generation: beyond high-throughput screening.靶点发现与潜在客户生成:超越高通量筛选
Nat Rev Drug Discov. 2003 May;2(5):369-78. doi: 10.1038/nrd1086.
10
A new generic column switching system for quantitation in cassette dosing using LC/MS/MS.一种用于盒式给药中定量分析的新型通用柱切换系统,采用液相色谱-串联质谱法(LC/MS/MS)。
J Pharm Biomed Anal. 2003 Apr 10;31(6):1089-99. doi: 10.1016/s0731-7085(02)00649-0.